Article info

Download PDFPDF
Trimethylamine N-oxide (TMAO): a new attractive target to decrease cardiovascular risk

Authors

  1. Correspondence to Dr. Mauro Vaccarezza, Curtin Medical School, Curtin University, Perth, WA 6102, Australia; mauro.vaccarezza{at}curtin.edu.au
View Full Text

Citation

Swanepoel I, Roberts A, Brauns C, et al
Trimethylamine N-oxide (TMAO): a new attractive target to decrease cardiovascular risk

Publication history

  • Received February 1, 2021
  • Revised March 2, 2021
  • Accepted March 6, 2021
  • First published March 31, 2021.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.